Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$700.03 - $830.35 $216,309 - $256,578
309 New
309 $222,000
Q3 2022

Nov 07, 2022

SELL
$573.97 - $724.32 $1,147 - $1,448
-2 Reduced 2.53%
77 $53,000
Q2 2022

Aug 04, 2022

BUY
$548.35 - $738.84 $4,386 - $5,910
8 Added 11.27%
79 $47,000
Q1 2022

May 10, 2022

BUY
$595.12 - $698.43 $8,331 - $9,778
14 Added 24.56%
71 $50,000
Q4 2021

Feb 09, 2022

SELL
$543.48 - $670.97 $543 - $670
-1 Reduced 1.72%
57 $36,000
Q3 2021

Nov 12, 2021

BUY
$574.03 - $680.96 $26,979 - $32,005
47 Added 427.27%
58 $35,000
Q1 2021

May 13, 2021

BUY
$446.73 - $548.2 $1,786 - $2,192
4 Added 57.14%
11 $5,000
Q4 2020

Feb 12, 2021

SELL
$478.3 - $607.98 $1,434 - $1,823
-3 Reduced 30.0%
7 $3,000
Q3 2020

Nov 13, 2020

BUY
$544.75 - $658.21 $1,634 - $1,974
3 Added 42.86%
10 $6,000
Q1 2020

May 07, 2020

SELL
$336.18 - $494.43 $3,361 - $4,944
-10 Reduced 58.82%
7 $3.42 Million
Q4 2019

Feb 07, 2020

SELL
$274.13 - $376.51 $1,644 - $2,259
-6 Reduced 26.09%
17 $6.38 Million
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $6,289 - $7,322
23 New
23 $6.38 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $77B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Evoke Wealth, LLC Portfolio

Follow Evoke Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.